Cancer Vaccines Congress 2025

Scientific insights on the latest advances in cancer vaccines were a highlight, with a strong focus on dendritic cell (DC)-based therapies for lung cancer in adults and glioma in pediatric patients, as well as vaccine development for HPV-related cancers.  Using the words of Jo Van Ginderachter from VUB:  “Delivery of DC-based immunotherapy via the bloodstream is not ideal due to significant loss—alternative, more efficient routes of administration like intradermal need to be investigated.”